138 related articles for article (PubMed ID: 19404209)
1. Gastrointestinal stromal tumor complicated by Streptococcus milleri bacteremia and liver abscess.
Kwon Y; Dang ND; Elmunzer BJ
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):824-6. PubMed ID: 19404209
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
5. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.
Maertens O; Prenen H; Debiec-Rychter M; Wozniak A; Sciot R; Pauwels P; De Wever I; Vermeesch JR; de Raedt T; De Paepe A; Speleman F; van Oosterom A; Messiaen L; Legius E
Hum Mol Genet; 2006 Mar; 15(6):1015-23. PubMed ID: 16461335
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of gastric stromal tumors.
Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumor as entry port for S. intermedius causing bacteremia and multiple liver abscesses. Case report and review of literature.
Benou C; Walter BM; Schlitter MA; Wilhelm D; Neu B; Schmid RM
Z Gastroenterol; 2016 Mar; 54(3):245-9. PubMed ID: 27043888
[TBL] [Abstract][Full Text] [Related]
9. Revision of gastrointestinal mesenchymal tumors.
Sornmayura P; Howannapakorn J; Karnsombut P
J Med Assoc Thai; 2009 Jan; 92(1):87-95. PubMed ID: 19260248
[TBL] [Abstract][Full Text] [Related]
10. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.
Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM
Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767
[TBL] [Abstract][Full Text] [Related]
11. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
Tang M; Li DQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
[TBL] [Abstract][Full Text] [Related]
12. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors (GISTs): a review.
Steigen SE; Eide TJ
APMIS; 2009 Feb; 117(2):73-86. PubMed ID: 19239429
[TBL] [Abstract][Full Text] [Related]
14. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
[TBL] [Abstract][Full Text] [Related]
15. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens.
Willmore-Payne C; Layfield LJ; Holden JA
Cancer; 2005 Jun; 105(3):165-70. PubMed ID: 15822120
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and immunohistochemical features of extragastrointestinal stromal tumors: report of two cases.
Nakagawa M; Akasaka Y; Kanai T; Takabayashi T; Miyazawa N
Surg Today; 2005; 35(4):336-40. PubMed ID: 15815855
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Lasota J; Miettinen M
Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
[TBL] [Abstract][Full Text] [Related]
18. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
[TBL] [Abstract][Full Text] [Related]
19. [Recent progress in gastrointestinal stromal tumor (GIST)].
Horiuchi H; Matsuya S; Konishi T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1495-501. PubMed ID: 12355934
[TBL] [Abstract][Full Text] [Related]
20. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA
Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
